Samantha Prout - Net Worth and Insider Trading

Samantha Prout Net Worth

The estimated net worth of Samantha Prout is at least $889,673 dollars as of 2024-11-10. Samantha Prout is the Chief Accounting Officer of Amicus Therapeutics Inc and owns about 80,953 shares of Amicus Therapeutics Inc (FOLD) stock worth over $889,673. Details can be seen in Samantha Prout's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samantha Prout has not made any transactions after 2024-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Samantha Prout

To

Samantha Prout Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samantha Prout owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .

Click here to see the complete history of Samantha Prout’s form 4 insider trades.

Insider Ownership Summary of Samantha Prout

Ticker Comapny Transaction Date Type of Owner
FOLD Amicus Therapeutics Inc 2024-01-09 Principal Accounting Officer

Samantha Prout Latest Holdings Summary

Samantha Prout currently owns a total of 1 stock. Samantha Prout owns 80,953 shares of Amicus Therapeutics Inc (FOLD) as of January 9, 2024, with a value of $889,673.

Latest Holdings of Samantha Prout

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOLD Amicus Therapeutics Inc 2024-01-09 80,953 10.99 889,673

Holding Weightings of Samantha Prout


Samantha Prout Form 4 Trading Tracker

According to the SEC Form 4 filings, Samantha Prout has made a total of 10 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 32,104 shares on January 9, 2024, which brought Samantha Prout around $449,456.

Insider Trading History of Samantha Prout

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samantha Prout Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samantha Prout Ownership Network

Ownership Network List of Samantha Prout

No Data

Ownership Network Relation of Samantha Prout

Insider Network Chart

Samantha Prout Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Samantha Prout is the Principal Accounting Officer of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Samantha Prout made 3 insider transaction in Amicus Therapeutics Inc (FOLD) with a net sale of 76,672. Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amicus Therapeutics Inc Insider Transactions

No Available Data

Samantha Prout Mailing Address

Above is the net worth, insider trading, and ownership report for Samantha Prout. You might contact Samantha Prout via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.